Drugs that contain Lanthanum Carbonate

1. Drug name - FOSRENOL

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7465465 TAKEDA PHARMS USA Pharmaceutical formulation comprising lanthanum compounds Aug, 2024

(1 year, 10 months from now)

US7381428 TAKEDA PHARMS USA Stabilized lanthanum carbonate compositions Aug, 2024

(1 year, 10 months from now)

US8980327 TAKEDA PHARMS USA Capsule and powder formulations containing lanthanum compounds Dec, 2030

(8 years from now)

US9023397 TAKEDA PHARMS USA Capsule and powder formulations containing lanthanum compounds Dec, 2030

(8 years from now)

Treatment: Reduction of serum phosphate in patients with end stage renal disease

Dosage: POWDER;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 1GM BASE POWDER;ORAL Prescription
EQ 750MG BASE POWDER;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.